Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Single-Masked, Multi-Center, Phase 2 Evaluation Of The Effect Of PDT Using Visudyne In Combination With Intravitreal Injection Of Either 0 mg, 1mg or 4mg of Kenalog In Subfoveal Occult & Minimally Classic CNV Secondary To ARMD

NCT00140803 is registered in ClinicalTrials.gov with Manhattan Eye, Ear & Throat Hospital as lead sponsor.

NCT NCT00140803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00140803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Single-Masked, Multi-Center, Phase 2 Evaluation Of The Effect Of PDT Using Visudyne In Combination With Intravitreal Injection Of Either 0 mg, 1mg or 4mg of Kenalog In Subfoveal Occult & Minimally Classic CNV Secondary To ARMD
Lead sponsor
Manhattan Eye, Ear & Throat Hospital
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2003
Completion date
January 31, 2007
Enrollment
106 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration